Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$411,605
in 5 filings

Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-31 Shah Gaurav CEO Exercise or conversion · Stock Option (Right to Buy) −75,880 0
2021-03-30 Shah Gaurav CEO Shares withheld for taxes −19,984 $41.80 $835K 614,092
2021-03-30 Shah Gaurav CEO Shares withheld for taxes −8,667 $42.80 $371K 594,108
2021-03-30 Shah Gaurav CEO Shares withheld for taxes −48,732 $43.86 $2.1M 545,376
2021-03-30 Shah Gaurav CEO Shares withheld for taxes −8,505 $44.34 $377K 536,871
2021-03-24 RTW INVESTMENTS, LP Director Other disposition −1,344,925 16,185,119
2021-03-24 Patel Kinnari Chief Operating Officer Exercise or conversion +55,869 $1.21 $68K 150,846
2021-03-24 Patel Kinnari Chief Operating Officer Exercise or conversion +38,093 $1.69 $64K 188,939
2021-03-24 Patel Kinnari Chief Operating Officer Exercise or conversion · Stock Option (Right to Buy) −55,869 0
2021-03-24 Patel Kinnari Chief Operating Officer Exercise or conversion · Stock Option (Right to Buy) −38,093 0
2021-02-04 Patel Kinnari Chief Operating Officer Grant or award · Stock Option (Right to Buy) +120,000 120,000
2021-02-04 Militello John Returned to the company · Stock Option (Right to Buy) +18,000 18,000
2021-02-04 Shah Gaurav President & CEO Grant or award · Stock Option (Right to Buy) +185,000 185,000
2021-02-04 Schwartz Jonathan David Chief Medical Officer Returned to the company · Stock Option (Right to Buy) +35,000 35,000
2021-02-01 Schwartz Jonathan David Chief Medical Officer Exercise or conversion +11,428 $1.69 $19K 11,428
2021-02-01 Schwartz Jonathan David Chief Medical Officer Exercise or conversion +213,101 $1.21 $258K 224,529
2021-02-01 Schwartz Jonathan David Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −11,428 0
2021-01-04 Garcia-Parada Carlos Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2020-12-28 Patel Kinnari Chief Operating Officer Sale −11,334 $56.51 $641K 100,404
2020-12-28 Patel Kinnari Chief Operating Officer Sale −5,427 $57.17 $310K 94,977

Page 23 of 27 · 538 trades